Back

Notification report

Full notification file


General information

Notification Number
B/NL/08/008

Member State to which the notification was sent
Netherlands

Date of acknowledgement from the Member State Competent Authority
03/10/2008

Title of the Project
A Phase I/II Trial of a Conditionally Replication-Competent Adenovirus (Delta-24-RGD) Administered by Convection Enhanced Delivery in Patients with Recurrent Glioblastoma Multiforme.

Proposed period of release:
01/01/2010 to 01/01/2013

Name of the Institute(s) or Company(ies)
Erasmus MC, Erasmus MC
s-Gravendijkwal 230
Afdeling Urologie
Rotterdam 3015 CE
The Netherlands;


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMPt been notified elsewhere by the same notifier?
No

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Genus: Mastadenovirus
Species: human adenovirus

Information relating to the recipient or parental organisms from wich the GMO is derived

Common Name	Genus	Species	Subspecies	Strain	Pathovar
Human adenovirus type 5	Mastadenovirus	human adenovirus	subgroup C	human serotype 5

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known